Latest Breaking News On - Merel opdam - Page 1 : comparemela.com

Three studies provide more data on risk for major adverse cardiovascular events with JAK inhibitors vs TNF inhibitors, as well as their efficacy in patients with different levels of risk.

Anja strangfeldEli lillyMaya buchRomain aymonManchester biomedical research centreUniversity of manchesterGeneva university hospitalsEuropean alliance of associationsGerman rheumatism research center berlinUniversity medicine berlinEuropean allianceEfficacy withWithout historyBiomedical research centreMedscape medical newsMerel opdam